The report provides a financial analysis and outlook for HCA Holdings, Inc., highlighting Q4 2013 results, 2014 guidance, and the impact of the Affordable Care Act (ACA). It reiterates a 'Buy' rating with a price target of $58, noting strong surgical trends and conservative ACA assumptions.
documents/vol00010-efta01462482-pdf.pdf
{"title":"Deutsche Bank Markets Research on HCA Holdings, Inc.","key_people":["Darren Lehrich","Joshua Kalenderian","Dana Nentin"],"document_date":"2014-02-04","document_type":"tabular","key_locations":["United States"],"document_subtype":"Financial Report","key_organizations":["Deutsche Bank","HCA Holdings, Inc."],"reference_numbers":["EFTA01462482","EFTA01462483","EFTA01462484","EFTA01462485","EFTA01462486","EFTA01462487","EFTA01462488","EFTA01462489","EFTA01462490","EFTA01462491","EFTA01462492","EFTA01462493","EFTA01462494","EFTA01462495","EFTA01462496","EFTA01462497","EFTA01462498","EFTA01462499","EFTA01462500","EFTA01462501","EFTA01462502","EFTA01462503","EFTA01462504","EFTA01462505","EFTA01462506","EFTA01462507","EFTA01462508","EFTA01462509","EFTA01462510","EFTA01462511","EFTA01462512","EFTA01462513","EFTA01462514","EFTA01462515","EFTA01462516","EFTA01462517","EFTA01462518","EFTA01462519","EFTA01462520","EFTA01462521","EFTA01462522","EFTA01462523","EFTA01462524","EFTA01462525","EFTA01462526","EFTA01462527","EFTA01462528","EFTA01462529","EFTA01462530","EFTA01462531","EFTA01462532","EFTA01462533","EFTA01462534","EFTA01462535","EFTA01462536","EFTA01462537","EFTA01462538","EFTA01462539","EFTA01462540","EFTA01462541"]}